Bio

• Biotechnology builder, leader, and strategic thinker with demonstrated ability to build and lead teams defining and implementing product launch and product lifecycle strategies • Passionate about diversity, equity, and inclusion in leadership • Deep experience developing strategies to establish scientific and medical credibility for companies pre-, peri-, and post-launch • Expertise in (and love for) early-stage companies; building and leading medical affairs/communications teams; supporting new diagnostics and therapeutics products through development, launch, and commercialization • Supported preparation of early-stage companies for initial public offering • Areas of expertise: oncology (solid tumor and hematology/oncology), molecular diagnostics (e.g., cfDNA-based assays), cancer screening, prenatal screening, genetics/genomics, next-generation sequencing, cancer research, chronic pain, and the general biology of proteins and nucleic acids